SynthesisBritish journal of cancer2013

Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors.

M D Kaymakcalan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.